Prognosis of Primary Myelofibrosis in the Genomic Era

Clinical Lymphoma, Myeloma and Leukemia - United States
doi 10.1016/j.clml.2016.02.031
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Driver Mutations and Prognosis in Primary Myelofibrosis: Mayo-Careggi MPN Alliance Study of 1,095 Patients

American Journal of Hematology
Hematology
2017English

Driver Mutation‐Specific Clinical and Genomic Correlates Differ Between Primary and Secondary Myelofibrosis

American Journal of Hematology
Hematology
2019English

Genetics in Genomic Era

Genetics Research International
GeneticsMolecular Biology
2015English

Bladder Cancer in the Genomic Era

Archives of Pathology and Laboratory Medicine
MedicineForensic MedicinePathologyMedical Laboratory Technology
2019English

Cancer Surgery in the Genomic Era

British Journal of Surgery
Surgery
2018English

New Insight Into the Treatment of Primary Myelofibrosis

Cancer therapy & Oncology International Journal
2018English

Heritable Cancer Risk in the Genomic Era

Pathology
Forensic MedicinePathology
2020English

Membrane Traffic in the Post-Genomic Era

Genome Biology
2010English

Spectroscopyin the Post-Genomic Era

Spectroscopy
2001English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy